feed,title,long_url,short_url
Benzinga,RxSight Is A Potential Acquisition Target: Analyst Highlights How LAL Revenue Mix Could Drive Share Price To $45+,https://benzinga.com/analyst-ratings/analyst-color/23/07/33203118/rxsight-is-a-potential-acquisition-target-analyst-highlights-how-lal-revenue-mix-co,https://da.gd/wOIu
